Literature DB >> 15388296

The effects of cocaine on the rate independent brain stimulation reward threshold in the mouse.

Brian M Gill1, Clifford M Knapp, Conan Kornetsky.   

Abstract

Interest in the development of mouse models of drug abuse liability has increased with the introduction of selective gene expression. In the rat, the ability of drugs to lower brain stimulation reward (BSR) thresholds often correlates with high abuse liability. Measurement of BSR thresholds using rate-independent methods decreases the influence of impaired motor performance on threshold determination that may confound studies of mutant mice. In the present experiment, the effects of cocaine on mouse BSR thresholds were assessed using a modification of the rate-independent psychophysical method of limits as current intensity was systematically varied in a series of descending and ascending discrete trials. Bipolar electrodes were implanted into the medial forebrain bundle of male C57Bl/6N mice and the effects of intraperitoneal saline and cocaine (5.0-30.0 mg/kg) on BSR thresholds were assessed using a within-subject crossover design. Threshold was defined as the intensity at which the mouse would respond in 50% of the trials. Threshold levels were significantly lowered below levels of control following cocaine administration with the maximum lowering following a 20.0-mg/kg dose. These findings indicate that cocaine increases the sensitivity of the mouse to BSR, and that BSR thresholds can be determined using rate-independent methods in this species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388296     DOI: 10.1016/j.pbb.2004.07.001

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.

Authors:  Astrid K Stoker; Berend Olivier; Athina Markou
Journal:  Behav Genet       Date:  2011-10-19       Impact factor: 2.805

2.  Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

Authors:  Aaron Ettenberg; Rick E Bernardi
Journal:  Pharmacol Biochem Behav       Date:  2006-10-24       Impact factor: 3.533

3.  Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice.

Authors:  Astrid K Stoker; Athina Markou
Journal:  Behav Brain Res       Date:  2011-05-05       Impact factor: 3.332

4.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

5.  Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.

Authors:  Astrid K Stoker; Michael J Marks; Athina Markou
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

6.  Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies.

Authors:  Paul M Johnson; Jonathan A Hollander; Paul J Kenny
Journal:  Pharmacol Biochem Behav       Date:  2008-04-04       Impact factor: 3.533

7.  Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test.

Authors:  Aaron Ettenberg; Rick E Bernardi
Journal:  Pharmacol Biochem Behav       Date:  2007-05-04       Impact factor: 3.533

8.  Assessing the motivational effects of ethanol in mice using a discrete-trial current-intensity intracranial self-stimulation procedure.

Authors:  Amanda M Barkley-Levenson; Andre Der-Avakian; Abraham A Palmer
Journal:  Drug Alcohol Depend       Date:  2019-12-16       Impact factor: 4.492

Review 9.  Glutamatergic transmission in drug reward: implications for drug addiction.

Authors:  Manoranjan S D'Souza
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.